The results illustrated that ANGPTL3 (69.50 ± 6.37 ng/mL vs. 67.80 ± 5.41 ng/mL, p = 0.84, Fig. 3a), ANGPTL4 (147.26 ± 12.46 ng/mL vs. 155.39 ± 15.00 ng/mL, p = 0.68, Fig.e 3b) and ANGPTL8 levels (1427.18 ± 285.44 pg/mL vs. 949.75 ± 52.80 pg/mL, p = 0.12, Fig. 3c) were not significantly different in T2D subjects according to the presence or absence of hypertension. This evidence concerns the gene ANGPTL8 and hypertensive disorder.